Compare DexCom, Inc. (DXCM) vs Intel Corp (INTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Intel Corp — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Intel Corp trades at $99.79 (market cap $492.85B). The key difference: Intel Corp is far larger — about 14.6× DexCom, Inc.'s market cap, and Intel Corp pays a 2.24% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | INTC | |
|---|---|---|
Market Cap | $33.79B | $492.85B |
Sector | Health | Technology |
52-Week High | $89.53 | $140.94 |
52-Week Low | $54.84 | $21.81 |
Enterprise Value | $33.24B | $513.66B |
Volume | — | 43,552,012 |
Dividend Yield | — | 2.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Intel Corp
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →
